BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/10/2026 3:38:02 AM | Browse: 3 | Download: 0
Publication Name World Journal of Experimental Medicine
Manuscript ID 120754
DOI 10.5493/wjem.120754
Country Greece
Category Endocrinology & Metabolism
Manuscript Type Minireviews
Article Title Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk
Manuscript Source Invited Manuscript
All Author List Christos Savvidis, Costas Thomopoulos and Ioannis Ilias
Funding Agency and Grant Number
Corresponding Author Ioannis Ilias, Director, MD, PhD, Department of Endocrinology, Hippocration General Hospital, No. 63 Evrou Street, Athens 11527, Greece. iiliasmd@yahoo.com
Key Words Melatonin; Prolactin; Heart failure; Peripartum cardiomyopathy; Hyperprolactinemia; Oxidative stress
Core Tip A single unpublished conference abstract reported an association between ≥ 1 year of melatonin therapy in adults with insomnia and increased new-onset heart failure, heart failure hospitalization, and all-cause mortality. Confounding by indication (insomnia as an independent cardiovascular risk factor) has not been excluded. We propose a speculative, hypothesis-generating mechanistic pathway involving prolactin (PRL): Melatonin may modulate hypothalamic dopaminergic tone, potentially increasing PRL release. Whether chronic melatonin use sustains hyperprolactinemia is an unconfirmed critical knowledge gap. In susceptible cardiovascular milieus with elevated oxidative stress and systemic inflammation, if sustained hyperprolactinemia occurs, it might theoretically favor PRL cleavage to the cardiotoxic 16-kDa fragment implicated in peripartum cardiomyopathy. This hypothesis requires validation in prospective studies before clinical implications can be drawn.
Citation Savvidis C, Thomopoulos C, Ilias I. Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk. World J Exp Med 2026; In press
PDF 120754-in-press.pdf
Received
2026-03-09 06:45
Peer-Review Started
2026-03-09 06:58
First Decision by Editorial Office Director
2026-04-21 10:03
Return for Revision
2026-04-21 10:03
Revised
2026-04-27 15:49
Publication Fee Transferred
Second Decision by Editor
2026-06-10 02:33
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-10 03:38
Articles in Press
2026-06-10 03:38
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com